Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Hepatitis E Virus Infections among Patients with Acute Febrile Jaundice in Burkina Faso.

Dimeglio C, Kania D, Mantono JM, Kagoné T, Zida S, Tassembedo S, Dicko A, Tinto B, Yaro S, Hien H, Rouamba J, Bicaba B, Medah I, Meda N, Traoré O, Tuaillon E, Abravanel F, Izopet J.

Viruses. 2019 Jun 14;11(6). pii: E554. doi: 10.3390/v11060554.

2.

A review of 65 years of human adenovirus seroprevalence.

Mennechet FJD, Paris O, Ouoba AR, Salazar Arenas S, Sirima SB, Takoudjou Dzomo GR, Diarra A, Traore IT, Kania D, Eichholz K, Weaver EA, Tuaillon E, Kremer EJ.

Expert Rev Vaccines. 2019 Jun;18(6):597-613. doi: 10.1080/14760584.2019.1588113. Epub 2019 May 27.

PMID:
31132024
3.

Genomic Survey of Bordetella pertussis Diversity, United States, 2000-2013.

Weigand MR, Williams MM, Peng Y, Kania D, Pawloski LC, Tondella ML; CDC Pertussis Working Group.

Emerg Infect Dis. 2019 Apr;25(4):780-783. doi: 10.3201/eid2504.180812.

4.

Improving Our Understanding of Salmonella enterica Serovar Paratyphi B through the Engineering and Testing of a Live Attenuated Vaccine Strain.

Higginson EE, Ramachandran G, Hazen TH, Kania DA, Rasko DA, Pasetti MF, Levine MM, Tennant SM.

mSphere. 2018 Nov 28;3(6). pii: e00474-18. doi: 10.1128/mSphere.00474-18.

5.

Combined testing for herpes simplex virus and Mycobacterium tuberculosis DNA in cerebrospinal fluid of patients with aseptic meningitis in Burkina Faso, West Africa.

Zida S, Kolia-Diafouka P, Kania D, Sotto A, Foulongne V, Bolloré K, Ouangraoua S, Méda N, Carrère-Kremer S, Van de Perre P, Tuaillon E.

J Clin Lab Anal. 2019 Mar;33(3):e22719. doi: 10.1002/jcla.22719. Epub 2018 Nov 25.

PMID:
30474140
6.

Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study.

Meda N, Tuaillon E, Kania D, Tiendrebeogo A, Pisoni A, Zida S, Bollore K, Medah I, Laureillard D, Moles JP, Nagot N, Nebie KY, Van de Perre P, Dujols P.

Bull World Health Organ. 2018 Nov 1;96(11):750-759. doi: 10.2471/BLT.18.208603. Epub 2018 Aug 29.

7.

Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.

Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni TD, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF; ANRS 12333 Study Group .

J Antimicrob Chemother. 2019 Feb 1;74(2):462-467. doi: 10.1093/jac/dky443.

8.

A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge.

Ndungo E, Randall A, Hazen TH, Kania DA, Trappl-Kimmons K, Liang X, Barry EM, Kotloff KL, Chakraborty S, Mani S, Rasko DA, Pasetti MF.

mSphere. 2018 Aug 1;3(4). pii: e00260-18. doi: 10.1128/mSphere.00260-18.

9.

Utilization of Lean Techniques in Pharmacy Residency Training: Modifying the PGY1 Management and Leadership Experience.

Arthur KJ, Kania DS, White CA.

Hosp Pharm. 2018 Jul;53(4):247-255. doi: 10.1177/0018578717741568. Epub 2017 Nov 16.

10.

Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso.

Zida S, Kania D, Sotto A, Brun M, Picardeau M, Castéra J, Bolloré K, Kagoné T, Traoré J, Ouoba A, Dujols P, Van de Perre P, Méda N, Tuaillon E.

Emerg Infect Dis. 2018 Aug;24(8):1569-1572. doi: 10.3201/eid2408.170436.

11.

Administration of Rotaglide™ solution for treating refractory severe radial artery spasm: A case report.

Raje V, Christopher S, Hopkinson DA, Kania DA, Jovin IS.

Cardiovasc Revasc Med. 2018 Dec;19(8S):56-57. doi: 10.1016/j.carrev.2018.05.001. Epub 2018 May 5.

PMID:
29779974
12.

Epidemiological data for hepatitis D in Africa.

Tuaillon E, Kania D, Gordien E, Van de Perre P, Dujols P.

Lancet Glob Health. 2018 Jan;6(1):e33. doi: 10.1016/S2214-109X(17)30463-1. No abstract available.

13.

The follow-up posturography in rehabilitation after total hip arthroplasty.

Pethe-Kania K, Opara JA, Kania D, Kidoń Z, Łukaszewicz T.

Acta Bioeng Biomech. 2017;19(1):97-104.

PMID:
28552931
15.

Semi-quantitative real-time PCR: A useful approach to identify persons with low replicative chronic hepatitis B.

Castéra-Guy J, Rubbo PA, Kania D, Lemoine M, Van de Perre P, Tuaillon E.

J Virol Methods. 2017 Jun;244:1-3. doi: 10.1016/j.jviromet.2017.01.003. Epub 2017 Jan 7.

PMID:
28069472
16.

Genome diversity of Shigella boydii.

Kania DA, Hazen TH, Hossain A, Nataro JP, Rasko DA.

Pathog Dis. 2016 Jun;74(4):ftw027. doi: 10.1093/femspd/ftw027. Epub 2016 Apr 6.

17.

Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients.

Zida S, Tuaillon E, Barro M, Kwimatouo Lekpa Franchard A, Kagoné T, Nacro B, Ouedraogo AS, Bolloré K, Sanosyan A, Plantier JC, Meda N, Sangaré L, Rouzioux C, Rouet F, Kania D.

J Clin Microbiol. 2016 Jun;54(6):1641-1643. doi: 10.1128/JCM.03372-15. Epub 2016 Mar 23.

18.

Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study.

Low AJ, Nagot N, Weiss HA, Konate I, Kania D, Segondy M, Meda N, van de Perre P, Mayaud P; Yerelon Study Group.

J Infect Dis. 2016 Mar 1;213(5):731-7. doi: 10.1093/infdis/jiv495. Epub 2015 Oct 15.

19.

Point mutations in Escherichia coli DNA pol V that confer resistance to non-cognate DNA damage also alter protein-protein interactions.

Hawver LA, Tehrani M, Antczak NM, Kania D, Muser S, Sefcikova J, Beuning PJ.

Mutat Res. 2015 Oct;780:1-14. doi: 10.1016/j.mrfmmm.2015.07.003. Epub 2015 Jul 13.

PMID:
26218456
20.

Performances of fourth generation HIV antigen/antibody assays on filter paper for detection of early HIV infections.

Kania D, Truong TN, Montoya A, Nagot N, Van de Perre P, Tuaillon E.

J Clin Virol. 2015 Jan;62:92-7. doi: 10.1016/j.jcv.2014.11.005. Epub 2014 Nov 13.

PMID:
25464967
21.

A variant of DC-SIGN gene promoter associated with resistance to HIV-1 in serodiscordant couples in Burkina Faso.

Kagoné TS, Bisseye C, Méda N, Testa J, Pietra V, Kania D, Yonli AT, Compaoré TR, Nikiéma JB, de Souza C, Simpore J.

Asian Pac J Trop Med. 2014 Sep;7S1:S93-6. doi: 10.1016/S1995-7645(14)60211-X.

22.

Use of reverse transcription-PCR-based assays for quantification of HIV-1 in dried blood spots requires specific HIV-1 RNA isolation for monitoring of antiretroviral treatment efficiency.

Rouet F, Kania D, Tuaillon E, Maiga A, Nouhin J, Rouzioux C, Descamps D, Plantier JC.

J Clin Microbiol. 2014 Jul;52(7):2740-1. doi: 10.1128/JCM.00962-14. No abstract available.

23.

Performance of two real-time PCR assays for hepatitis B virus DNA detection and quantitation.

Kania D, Ottomani L, Meda N, Peries M, Dujols P, Bolloré K, Rénier W, Viljoen J, Ducos J, Van de Perre P, Tuaillon E.

J Virol Methods. 2014 Jun;201:24-30. doi: 10.1016/j.jviromet.2014.01.015. Epub 2014 Feb 18.

PMID:
24560781
24.

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M; ANRS 12235 Study Group.

J Clin Microbiol. 2014 Feb;52(2):578-86. doi: 10.1128/JCM.02860-13. Epub 2013 Dec 11.

25.

Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.

Low AJ, Konate I, Nagot N, Weiss HA, Kania D, Vickerman P, Segondy M, Mabey D, Pillay D, Meda N, van de Perre P, Mayaud P; Yerelon Study Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):237-45. doi: 10.1097/QAI.0000000000000049.

26.

Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LX, Delaporte E, Chaix ML, Peeters M, Ayouba A; ANRS 12186 Study Group.

Clin Infect Dis. 2014 Jan;58(1):99-109. doi: 10.1093/cid/cit627. Epub 2013 Sep 27.

PMID:
24076968
27.

Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.

Kania D, Bekalé AM, Nagot N, Mondain AM, Ottomani L, Meda N, Traoré M, Ouédraogo JB, Ducos J, Van de Perre P, Tuaillon E.

Clin Microbiol Infect. 2013 Dec;19(12):E533-41. doi: 10.1111/1469-0691.12292. Epub 2013 Jul 31.

28.

Anaerobic and aerobic performance of elite female and male snowboarders.

Zebrowska A, Zyła D, Kania D, Langfort J.

J Hum Kinet. 2012 Oct;34:81-8. doi: 10.2478/v10078-012-0066-9. Epub 2012 Oct 23.

29.

Potential new treatments for diabetic kidney disease.

Kania DS, Smith CT, Nash CL, Gonzalvo JD, Bittner A, Shepler BM.

Med Clin North Am. 2013 Jan;97(1):115-34. doi: 10.1016/j.mcna.2012.10.004. Epub 2012 Dec 7. Review.

PMID:
23290734
30.

Long-term hepatitis B virus surface antigen decay in HIV-1/hepatitis B virus-coinfected adults initiating a tenofovir-containing regimen.

Tuaillon E, Lozano C, Kuster N, Poinso A, Kania D, Nagot N, Mondain AM, Pageaux GP, Ducos J, Van de Perre P, Reynes J.

J Clin Microbiol. 2012 Sep;50(9):3096-8. doi: 10.1128/JCM.00971-12. Epub 2012 Jul 3.

31.

Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.

Tuaillon E, Mondain AM, Nagot N, Ottomani L, Kania D, Nogue E, Rubbo PA, Pageaux GP, Van de Perre P, Ducos J.

PLoS One. 2012;7(3):e32143. doi: 10.1371/journal.pone.0032143. Epub 2012 Mar 5.

32.

Minimally invasive surgical technique in the management of perianal fistulas using the Surgisis® AFP material.

Kania D.

Pol Przegl Chir. 2011 Jul;83(7):392-402. doi: 10.2478/v10035-011-0063-z. Review. No abstract available.

PMID:
22166669
33.

Saxagliptin: a clinical review in the treatment of type 2 diabetes mellitus.

Kania DS, Gonzalvo JD, Weber ZA.

Clin Ther. 2011 Aug;33(8):1005-22. doi: 10.1016/j.clinthera.2011.06.016. Epub 2011 Jul 28. Review.

PMID:
21802144
34.

Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.

Rouet F, Liégeois F, Mouinga-Ondémé A, Kania D, Viljoen J, Wambua S, Ngo-Giang-Huong N, Ménan H, Peeters M, Nerrienet E.

Expert Opin Med Diagn. 2011 May;5(3):183-202. doi: 10.1517/17530059.2011.566860. Epub 2011 Mar 29.

PMID:
23484497
35.

Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso.

Viljoen J, Gampini S, Danaviah S, Valéa D, Pillay S, Kania D, Méda N, Newell ML, Van de Perre P, Rouet F; World Health Organization/ANRS 1289 Kesho Bora Study Group.

J Acquir Immune Defic Syndr. 2010 Nov;55(3):290-8. doi: 10.1097/QAI.0b013e3181edaaf5.

PMID:
20700058
36.

Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.

Kania D, Fao P, Valéa D, Gouem C, Kagoné T, Hien H, Somda P, Ouédraogo P, Drabo A, Gampini S, Méda N, Diagbouga S, Van de Perre P, Rouet F; WHO/ANRS 1289 Kesho Bora Study Group in Burkina Faso.

J Clin Microbiol. 2010 Apr;48(4):1333-6. doi: 10.1128/JCM.01734-09. Epub 2010 Feb 3.

37.

[Antenatal transmission of hepatitis B virus in an area of HIV moderate prevalence, Burkina Faso].

Sangaré L, Sombié R, Combasséré AW, Kouanda A, Kania D, Zerbo O, Lankoandé J.

Bull Soc Pathol Exot. 2009 Oct;102(4):226-9. French.

PMID:
19950539
38.

A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso.

Kania D, Sangaré L, Sakandé J, Koanda A, Nébié YK, Zerbo O, Combasséré AW, Guissou IP, Rouet F.

Transfusion. 2009 Oct;49(10):2237-40. doi: 10.1111/j.1537-2995.2009.02276.x. Epub 2009 Jul 6.

PMID:
19903285
39.

Myoelectrical activity of small intestine in rats with experimental Parkinson's disease.

Banach T, Zurowski D, Kania D, Thor PJ.

Folia Med Cracov. 2005;46(3-4):119-24.

PMID:
17252994
40.

Update on personal digital assistant applications for the healthcare provider.

Keplar KE, Urbanski CJ, Kania DS.

Ann Pharmacother. 2005 May;39(5):892-907. Epub 2005 Mar 29. Review.

PMID:
15797983
41.

Seizures related to use of imipenem-cilastatin.

Lane M, Kania D, Rapp RP.

Am J Health Syst Pharm. 1996 Jul 1;53(13):1605-6. No abstract available.

PMID:
8809285
42.

Fabrication of extreme-ultraviolet point-diffraction interferometer aperture arrays.

Spallas JP, Hostetler RE, Sommargren GE, Kania DR.

Appl Opt. 1995 Oct 1;34(28):6393-8. doi: 10.1364/AO.34.006393.

PMID:
21060486
43.

Biocompatibility of chemical-vapour-deposited diamond.

Tang L, Tsai C, Gerberich WW, Kruckeberg L, Kania DR.

Biomaterials. 1995 Apr;16(6):483-8.

PMID:
7654876
44.

Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density.

Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB.

J Am Geriatr Soc. 1995 Mar;43(3):236-9.

PMID:
7884109
45.

Space-resolved density diagnostic of a highly ionized holmium (Z=67) laser-produced plasma from 3d104l-3d104l' Cu I-like lines.

Mandelbaum P, Behar E, Seely JF, Feldman U, Brown CM, Hammel BA, Back CA, Lee RW, Kania DR, Bar-Shalom A.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1994 Jun;49(6):5652-5655. No abstract available.

PMID:
9961889
46.

Density and temperature sensitive features in high temperature plasma L-shell xenon emission spectra.

Keane CJ, Hammel BA, Osterheld AL, Kania DR.

Phys Rev Lett. 1994 May 9;72(19):3029-3032. No abstract available.

PMID:
10056049
47.

Polycrystalline CVD Diamond Films with High Electrical Mobility.

Plano MA, Landstrass MI, Pan LS, Han S, Kania DR, McWilliams S, Ager JW 3rd.

Science. 1993 May 28;260(5112):1310-2.

PMID:
17755424
48.

X-ray spectroscopic measurements of high densities and temperatures from indirectly driven inertial confinement fusion capsules.

Hammel BA, Keane CJ, Cable MD, Kania DR, Kilkenny JD, Lee RW, Pasha R.

Phys Rev Lett. 1993 Mar 1;70(9):1263-1266. No abstract available.

PMID:
10054332
49.

Characterization of an x-ray-flux source for the production of high-energy-density plasmas.

Kania DR, Kornblum H, Hammel BA, Seely J, Brown C, Feldman U, Glendinning G, Young P, Hsieh E, Hennesian M, DaSilva L, MacGowan BJ, Montgomery DS, Back CA, Doyas R, Edwards J, Lee RW.

Phys Rev A. 1992 Dec 15;46(12):7853-7868. No abstract available.

PMID:
9908136
50.

Laser-driven planar Rayleigh-Taylor instability experiments.

Glendinning SG, Weber SV, Bell P, DaSilva LB, Dixit SN, Henesian MA, Kania DR, Kilkenny JD, Powell HT, Wallace RJ, Wegner PJ, Knauer JP, Verdon CP.

Phys Rev Lett. 1992 Aug 24;69(8):1201-1204. No abstract available.

PMID:
10047153

Supplemental Content

Support Center